KRT5 and breast carcinoma: We identified the molecular subtypes of breast cancer in 753 out of 885 patients by the combination of four immunohistochemical markers (HER2-positive, luminal ER-positive and basal-like CK5/6, and/or EGFR-positive breast cancer).